India,
DGHS drops Ivermectin, Doxycycline from Covid-19 treatment; ICMR rules unchanged
The revised guidelines have also dropped drugs such as hydroxychloroquine, ivermectin, doxycycline, zinc and multivitamins, that were earlier prescribed by doctors to treat asymptomatic or mildly symptomatic Covid-19 patients.
The Union Health Ministry and Family Welfare's directorate general of health services (DGHS) has issued revised guidelines to stop the use of Ivermectin and Doxycycline in Covid-19 treatment. The new guidelines have dropped all medicines, except antipyretic and antitussive, for asymptomatic and mild cases.
The revised guidelines have also dropped drugs such as hydroxychloroquine, ivermectin, doxycycline, zinc and multivitamins, that were earlier prescribed by doctors to treat asymptomatic or mildly symptomatic Covid-19 patients.
www.indiatoday.in
Drugmakers in Japan struggle to keep pace in COVID-19 medicine race
The Kitasato Institute has been conducting a clinical trial for ivermectin, a drug used to treat parasitic diseases, to evaluate the efficacy of the drug. The drug was discovered by Kitasato University’s distinguished emeritus professor Satoshi Omura, a Nobel Prize winner. While there is conflicting clinical trial evidence on the efficacy of the drug, Haruo Ozaki, president of the Tokyo Medical Association, has proposed the emergency use of the treatment for patients recuperating at home to prevent serious complications from the disease.
No applications for drugs specifically tailored to COVID-19 have been filed yet, as domestic pharmaceutical companies have not invested heavily enough in biomedicine.
www.japantimes.co.jp
Ivermectin still not proven as COVID drug
Many posts online containing the video make it seem like the video was filmed in August, however it was filmed in February. Seven months later and Japan has not approved of Ivermectin to be used to treat COVID-19.
Ivermectin has been called a wonder drug, and some people are wondering if it can, or should, be used to treat COVID-19. While misinformation flies online, the Centers for Disease Control and Prevention warn against using the drug.
www.wcpo.com
The growing debate over the use of ivermectin to combat COVID-19
Avermectin, originally developed in 1970, served as a way to fight parasitic infections in livestock. In 1981, an adapted variation of those avermectin compounds called ivermectin was introduced, and in 1986, 46 countries authorized the drug’s use in combatting parasitic infections in cattle, sheep and other animals. The development of ivermectin for use against human parasitic infections led to its creators — Satoshi Omura of Kitasato University in Tokyo and William Campbell of the pharmaceutical company Merck — sharing the 2015 Nobel Prize in Physiology or Medicine.
As the delta variant continues its substantial spread in the United States and worldwide, one drug in particular has come under scrutiny by health officials in its ability to combat
www.nrtoday.com
So the creator of Ivermectin says that it should be studied. Yeah, no conflict of interest.
On your 0.01% not recovering, if you count deaths. But the people that end up in hospital and have serious side effects afterward? My sister recoverd from SARS, almost lost her. Now she has partial lung capacity and has problems in life due to it. Many Covid survivors will end up with long term health issues. Hospitals filling up and shedding elective surgeries, as one example, will cause long term health issues that would be treated if it were not for covid. Your pass/fail number of 0.01 does not take all this into account. Also the cost to the medical system, your insurance rates will be going up.
Americans have lot of health issues that help increase hospitalizations and deaths, you are right. But those are not problems that can be turned around in a month at the gym.